Business Today
Subscribe
PMS TodayUS NewsIndiaUPSTARTWeatherBT ShortsNRIEducationElection
BT India 100BT GolfBT Mindrush
Search

COMPANIES

No Data Found

NEWS

No Data Found
Advertisement
News
markets
stocks
Ishita Drugs & Industries Ltd
Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 300
Aug 07, 2025 Closed
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹72.85
₹-0.74 (-1.01%)
72.85Low
Today’s Performance
75.00High
62.35Low
52 Week’s Performance
99.64High

bt_logoStock Performance

  • 1 Day-1.01%
  • 1 Week-6.20%
  • 1 Month-9.82%
  • 3 Months-0.08%
  • 6 Months-10.80%
  • 1 Year-9.71%
  • 3 Years16.91%
  • 5 Years29.19%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta0.21
  • 52-Week Low (₹)62.35
  • 52-Week High (₹)99.64
  • Price-to-Book (X)*2.04
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*25.38
  • Earnings Per Share (₹)2.90
  • Market Cap (₹ Cr.)*22.00
* Values as of last close price

bt_logoCOMPETITORS

BT TV

Lupin’s FY26 Momentum Rides On U.S. Growth12:43Lupin’s FY26 Momentum Rides On U.S. Growth
Uttarkashi Cloudburst: Climate Change In The Himalayas | Flash Floods, Glacial Melts, And Climate Crisis3:28Uttarkashi Cloudburst: Climate Change In The Himalayas | Flash Floods, Glacial Melts, And Climate
Telangana’s 42% Quota Struggle: CM Reddy Leads Delhi Dharna For Backward Classes3:23Telangana’s 42% Quota Struggle: CM Reddy Leads Delhi Dharna For Backward Classes
Shashi Tharoor Slams Trump’s 50% Tariff on Indian Goods : “Major Blow to Exports, Time to Diversify”3:11Shashi Tharoor Slams Trump’s 50% Tariff On Indian Goods : “Major Blow To Exports, Time To Diversify”
Uttarakhand Cloudburst Wrecks Villages | Army Leads Rescue Ops, CM Dhami Inspects Situation4:32Uttarakhand Cloudburst Wrecks Villages | Army Leads Rescue Ops, CM Dhami Inspects Situation
Uttarkashi Cloudburst: Are Indians Adequately Insured? Coverage, Gov Schemes & Claims Explained14:53Uttarkashi Cloudburst: Are Indians Adequately Insured? Coverage, Gov Schemes & Claims Explained
This Fund Beat The Market For 25 Years! SBI Contra Fund Review29:14This Fund Beat The Market For 25 Years! SBI Contra Fund Review
PVR INOX Q1 Results: Revenue Soared 23% At ₹1,470 Cr. Expert Sees ₹1,600 Target | OTT Threat Fading?2:58PVR INOX Q1 Results: Revenue Soared 23% At ₹1,470 Cr. Expert Sees ₹1,600 Target | OTT Threat Fading?
Share Market News: How Are Markets Moving As RBI Keeps The Repo Rate Unchanged At 5.5%? | Nifty LIVE12:00Share Market News: How Are Markets Moving As RBI Keeps The Repo Rate Unchanged At 5.5%? | Nifty LIVE
VinFast Rolls Out First EV From Tamil Nadu Plant | Check Out Features, Model, Safety & More6:33VinFast Rolls Out First EV From Tamil Nadu Plant | Check Out Features, Model, Safety & More
View more

bt_logoFAQ's

What was Ishita Drugs & Industries Ltd share price previously?
Ishita Drugs & Industries Ltd share price was down by -1.01% from the previous closing price of ₹73.59.
Who are peers of Ishita Drugs & Industries Ltd?
The peers of Ishita Drugs & Industries Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Ishita Drugs & Industries Ltd?
The promotor/promotors of Ishita Drugs & Industries Ltd are Jagdish Agrawal, Abha Agrawal, Arvind Sapkal, Srushti Pandya, Dhwani Jaypalsinh Solanki.
What has been 52-week high of Ishita Drugs & Industries Ltd stocks?
The highest price of Ishita Drugs & Industries Ltd stock is ₹99.64 in the last 52-week.
What is the share price of Ishita Drugs & Industries Ltd (ISHITADR) today on BSE?
As on Aug 07, 2025 Ishita Drugs & Industries Ltd (ISHITADR)’s share price on BSE is Rs 72.85
What is the market cap of Ishita Drugs & Industries Ltd (ISHITADR)?
The current market capitalisation of Ishita Drugs & Industries Ltd (ISHITADR) is 22.00 crores
What is Ishita Drugs & Industries Ltd Share symbol?
The symbol of Ishita Drugs & Industries Ltd is .
What is the PE ratio of Ishita Drugs & Industries Ltd (ISHITADR)?
The current PE ratio of Ishita Drugs & Industries Ltd (ISHITADR) is 25.38.
What is the PB ratio of Ishita Drugs & Industries Ltd (ISHITADR)?
The current PB ratio of Ishita Drugs & Industries Ltd (ISHITADR) is 2.04.
Today’s High & Low share prices of Ishita Drugs & Industries Ltd (ISHITADR) on BSE?
Today, the share price of Ishita Drugs & Industries Ltd (ISHITADR) on BSE touched a high of Rs 75 and a low of Rs 72.85
What price did Ishita Drugs & Industries Ltd (ISHITADR) shares open on the BSE today?
On BSE, the share price of Ishita Drugs & Industries Ltd (ISHITADR) opened at Rs 75
What is the 52-week high of Ishita Drugs & Industries Ltd (ISHITADR)?
The 52-week high price of Ishita Drugs & Industries Ltd (ISHITADR) is Rs 99.64
What is the 52-week low of Ishita Drugs & Industries Ltd (ISHITADR)?
The 52-week low price of Ishita Drugs & Industries Ltd (ISHITADR) is Rs 62.35

bt_logoAbout Ishita Drugs

Ishita Drugs & Industries Ltd, incorporated in the year 1992, has its registered office in Survey No 179/1 Taluka Sanand, Village Vasna-Iyava, Ahmedabad, Gujarat, 382170. The main industry in which Ishita Drugs & Industries Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Ishita Drugs & Industries Ltd is/are jaymin Shah & Associates. In the main management, is chairman and Srushti Pandya is the company secretary for Ishita Drugs & Industries Ltd.

  • JA
    Jagdish AgrawalManaging Director
  • AA
    Abha AgrawalNon Executive Director
  • AS
    Arvind SapkalDirector
  • SP
    Srushti PandyaCompany Sec. & Compli. Officer
  • DJS
    Dhwani Jaypalsinh SolankiIndependent Director

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.